Life Sciences organizations face growing pressure to generate real-world evidence (RWE) faster and at greater scale-for internal decision-making, publication, and external stakeholders, including regulators and payers.Speed is now non-negotiable, but…

Read more

Healthcare has made real progress on digital access. Portals are common. APIs are expanding. Federal policy continues to reinforce what should be obvious: patients have a right to their own…

Read more

We have previously articulated the case for systematic, integrated RWE generation beginning early in drug development – not as an afterthought, but as a foundational component of strategy. This includes…

Read more

Life sciences organizations have long struggled with fragmented, time-intensive processes for discovering, assessing, and purchasing real-world data (RWD). These bottlenecks delay evidence generation, slow clinical and commercial decision-making, and increase…

Read more

Medical coding is no longer a downstream function with a single destination. Coded data now flows across reimbursement, analytics, quality reporting, and research. As that reuse accelerates, accuracy stops being…

Read more